osimertinib
astrazeneca
['lcsm,(-blcsm)', 'osimertinib']
neoadjuvant osimertinib phase 2; small study. primary ep = mpr was low at 15%; 11% were not operated but most of these got radical rt. suppose the real q would be how other sact options might be integrated with osi? chemo/io/bev #lcsm #asco23 
Consultant Medical Oncologist, UK. Views are hypothesis generating discourse. Post COVID dabbling in garden.